Table 3. .
Sites and timing of relapses in young NPC patients
| Study | N | Local failure | Metastatic failure or combined | Time of relapse |
| Sahai, 20179 | 41 | 2.4% | 41% | Med. 9 months |
| Guo, 201645 | 95 | 5% | 16% | Med. 29 months |
| Greenwalt,201675 | 10 | 5% | 40% | NR |
| Liu, 201427 | 165 | 5% | 24% | All <15 months |
| Hu, 2013 (78) | 95 | 14% | 37% | NR |
| Daoud, 201374 | 69 | 1.4% | NR | All <24 months |
| Cheuk, 201112 | 59 | 5% | 25% | NR |
| Afqir, 200910 | 46 | 0% | 29% | NR |
N, number of patients; NPC, nasopharyngeal carcinoma;NR, not reported.